LeMaitre Vascular
LMAT
297 hedge funds and large institutions have $1.84B invested in LeMaitre Vascular in 2025 Q3 according to their latest regulatory filings, with 43 funds opening new positions, 104 increasing their positions, 106 reducing their positions, and 24 closing their positions.
79% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 24
5% more funds holding
Funds holding: 283 → 297 (+14)
4% more capital invested
Capital invested by funds: $1.76B → $1.84B (+$78.7M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.94% less ownership
Funds ownership: 93.62% → 92.67% (-0.94%)
2% less repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 106
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.5M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
+$19.4M |
| 3 |
Osaic Holdings
Scottsdale,
Arizona
|
+$8.2M |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
+$6.18M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$4.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$16.4M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$11.5M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$10.1M |
| 4 |
AIC
AWM Investment Company
New York
|
-$6.07M |
| 5 |
BlackRock
New York
|
-$6.06M |
LMAT Hedge Fund Activity: Q3 2025 in Review
297 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q3 2025, worth a combined $1.84B — up 4.5% from $1.76B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new LMAT positions and 24 closed out — a net gain of 19 holders — while 104 added to existing stakes and 106 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $21.5M. The largest seller was Millennium Management, cutting an estimated $16.4M.
- 297 institutional investors held LeMaitre Vascular (LMAT) as of Q3 2025, up from 283 in Q2 2025.
- Funds reported $1.84B of LeMaitre Vascular stock for Q3 2025, up 4.5% quarter-over-quarter.
- 43 funds opened new LeMaitre Vascular positions in Q3 2025 and 24 closed out, a net change of +19 holders.
- The largest LeMaitre Vascular buyer in Q3 2025 was T. Rowe Price Associates, an estimated $21.5M added.
- The largest LeMaitre Vascular seller in Q3 2025 was Millennium Management, an estimated $16.4M sold.
Based on aggregated 13F filings for Q3 2025.